Risk of hepatocellular carcinoma occurrence after antiviral therapy for patients with chronic hepatitis C Infection: a systematic review and meta-analysis

Members of APASL viral elimination task force (in no particular order). George LAU (Humanity and Health Clinical Trial Center, Humanity and Health Medical group, Hong Kong SAR, China), Masao OMAYA (Yamanashi Hospitals (Central and Kita) Organization, 1-1-1 Fujimi, Kofu-shi, Yamanashi, 400-8506, Japan), Jidong JIA (Liver Research Center, Beijing Friendship Hospital, Capital Medical University, Beijing, China), Hui ZHUANG (Department of Microbiology and Centre for Infectious Diseases, Peking University Health Science Centre, Beijing, China), Yu-Mei WEN (Key Laboratory Medical Molecular Virology, Ministry of Education/Health, School of Basic Medical Sciences, Shanghai Medical College, Fudan University, Shanghai, China), Xinxin ZHANG (Department of Infectious Disease, Research Laboratory of Clinical Virology, Ruijin Hospital, Shanghai Jiaotong University, School of Medicine, Shanghai, China), Jin Mo YANG (Department of Internal Medicine, St. Vincent’s Hospital, College of Medicine, The Catholic University of Korea, Seoul 06591, Korea), Tawesak TANWANDEE (Division of Gastroenterology, Department of Medicine, Faculty of Medicine Siriraj Hospital, Mahidol University, Thailand), Diana PAYAWAL (Department of Medicine, Cardinal Santos Medical Center, Mandaluyong, Philippines), Saeed HAMID (Aga Khan University, Karachi-74800, Pakistan), SK SARIN (Department of Hepatology, Institute of Liver and Biliary Sciences, New Delhi, India), Jing CHEN (JC School of Public Health and Primary Care, Faculty of Medicine, Chinese University of Hong Kong, Hong Kong SAR, China), Dong JI (Senior Department of Hepatology, Fifth Medical Center of Chinese PLA General Hospital, Beijing 100039, China), Wenhong ZHANG (Department of Infectious Diseases, National Medical Center for Infectious Diseases, Shanghai Key Laboratory of Infectious Diseases and Biosafety Emergency Response, Huashan Hospital, Fudan University, Shanghai, 200040, China), Fusheng WANG (Treatment and Research Center for Infectious Diseases, The Fifth Medical Center of PLA General Hospital, National Clinical Research Center for Infectious Diseases, Beijing 100039, China), Jiangao FAN (Center for Fatty Liver, Department of Gastroenterology, Xin Hua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China), Lungen LU (Department of Gastroenterology, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China), Xiaoguang DOU (Department of Infectious Diseases, Shengjing Hospital of China Medical University, Shenyang 110000, China), Xiaolong QI (Center of portal hypertension, Department of radiology, Zhongda Hospital, School of Medicine, Southeast University, Nanjing, China), Qin NING (Department and Institute of Infectious Disease, Tongji Hospital of Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China), Hong YOU (Beijing Friendship Hospital, Capital Medical University, Beijing, China), Hong REN (Institute for Viral Hepatitis, Department of Infectious Diseases, The Second Affiliated Hospital of Chongqing Medical University, Chongqing, China), Jian SUN (Department of Infectious Diseases, Nanfang Hospital, Southern Medical University, 510515, Guangzhou, China), Ming-Lung YU (Hepatobiliary Division, Department of Internal Medicine, Kaohsiung Medical University Hospital; College of Medicine and Center for Liquid Biopsy and Cohort Research, Kaohsiung Medical University, Kaohsiung, Taiwan; School of Medicine and Doctoral Program of Clinical and Experimental Medicine, College of Medicine and Center of Excellence for Metabolic Associated Fatty Liver Disease, National Sun Yat-sen University, Kaohsiung, Taiwan), Jacob George (School of Medicine, University of Sydney, Sydney, New South Wales, Australia), George BB Goh (Department of Gastroenterology & Hepatology, Singapore General Hospital, Singapore, Duke-NUS Graduate Medical School, Singapore), Sang Hoon Ahn (Department of Internal Medicine, Institute of Gastroenterology, Liver Cirrhosis Clinical Research Center, Yonsei University College of Medicine, Seoul, South Korea), Rino Alvani Gani (Hepatobiliary Division, Department of Internal Medicine, Faculty of Medicine Universitas Indonesia, Cipto Mangunkusumo National General Hospital, Jakarta, Indonesia), Mohd Ismail Merican (Ministry of Health, Malaysia, Kuala Lumpur), Khin Maung Win (Yangon GI & Liver Centre, Yangon, Myanmar), Oidov Baatarkhuu (Department of Infectious Diseases, Mongolian National University of Medical Sciences, Mongolia), Hasmik Ghazinyan (Department of Hepatology, Nork Clinical Infectious Hospital (CJSC), Yerevan, Armenia), Manal H El-Sayed (Department of Pediatrics, Faculty of Medicine, Clinical Research Center, Ain Shams University, Cairo, Egypt), Anuchit Chutaputti (Section of Digestive and Liver Diseases, Department of Medicine, Phramongkutklao Hospital, Bangkok, Thailand), Phunchai Charatcharoenwitthaya (Faculty of Medicine Siriraj Hospital, Bangkok, Thailand), Pei-jer Chen, Jia-Horng Kao (Division of Gastroenterology and Hepatology, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan), Rosmawati Mohamed (Gastroenterology and Hepatology Unit, Department of Medicine, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia), Rakhi Maiwall, Manoj Kumar (Department of Hepatology, Institute of Liver and Biliary Sciences, New Delhi, India), Rakesh Aggarwal (Department of Gastroenterology, Jawaharlal Institute of Postgraduate Medical Education and Research, Puducherry, 605 006, India), Alexander Thompson (St. Vincent’s Hospital Melbourne and the University of Melbourne, Melbourne, Australia), Yoon Jun Kim (Department of Internal Medicine and Liver Research Institute, Seoul National University College of Medicine, 101 Daehak-no, Jongno-gu, Seoul 03080, Korea), Grace WONG (Department of Medicine & Therapeutics; Medical Data Analytics Centre (MDAC) & Center for Liver Health, Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong SAR), Fu GAO (CAS Key laboratory of Pathogenic Microbiology & Immunology, Institute of Microbiology Chinese Academy of Sciences, Beijing, China), Gang LI (Department of Infectious Diseases, the Third Affiliated Hospital, Sun Yat-sen University, Guangzhou, China), Jun-Qi NIU (Department of Hepatology, Center for Pathogen Biology and Infectious Diseases, First Hospital of Jilin University, Changchun, Jilin Province, China), Yu WANG (Chinese Foundation for Hepatitis Prevention and Control, China), Zhi-Liang GAO (Department of Infectious Diseases, the Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, China).

留言 (0)

沒有登入
gif